After largely pausing onsite facility inspections during the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) has resumed this type of oversight in the past 18 months. However, several recent in-market events involving contaminated eye …
The COVID-19 pandemic has changed the business world in numerous ways. Virtual meetings, remote work schedules, travel restrictions, and supply chain volatility are just a few examples of the new reality we’ll inevitably face ongoing. To that list yo…
We’re in the business of being prepared to respond to unthinkable situations. And while bad weather warnings indicate the potential for a surge event, there’s a new storm brewing that could hit anywhere, anytime and with little notice. The potentiall…
As COVID-19 begins to subside, the U.S. Food and Drug Administration (FDA), like other federal agencies is shifting its focus away from the pandemic and back toward more routine issues. As an example, the FDA recently published its final guidance out…
Foreword by Chris Harvey, SVP client services at Sedgwick: Welcome to the latest edition of spotlight. Spotlight is our way of sharing insights and perspectives from our strategic partners – lawyers, insurers, risk managers and crisis communicatio…
With more electric vehicles (EVs) on the road, people are beginning to wonder whether the technology is safe. The National Highway Traffic Safety Administration (NHTSA) is concerned, too. This month, NHTSA announced it will be zeroing in on the ris…
Risks to an increasingly modernized, technological and integrated society have greatly increased our threat of events with catastrophic consequences. Frequency and scale of these events as well as natural disasters are increasing along with the econo…